Abstract:In this work, Surface-enhanced Raman spectroscopy (SERS) involving blood plasma was investigated; the objective was to determine whether this approach could distinguish prostate cancer with benign prostatic hyperplasia. The experimental samples were prepared by blood plasma mixed with the silver colloid over an aluminum plate substrate. A total of 14 SERS spectra for prostate cancer (PCa) and 14 spectra for benign prostatic hyperplasia (BPH) were successfully gathered from patients who came from Fujian Provincial Hospital. Difference spectrum analysis combined with the assignment of Raman bands indicated that there were subtle but distinct changes between prostate cancer (PCa) and benign prostatic hyperplasia (BPH), which could be related to the level of prostate specific antigen (PSA); because it has been reported that the level of PSA is increased in men who have prostate cancer compared with those with benign prostatic hyperplasia (BPH). To further make clear the difference of Prostate cancer (PCa) and benign prostatic hyperplasia (BPH), the spectral data was combined with multivariate analysis processes. Principal component analysis (PCA), as a spectral dimensionality reduction approach, and in conjunction with linear discriminant analysis (LDA) were employed to identify the samples, to build diagnostic algorithms. The leave-one-out cross-validation method was used to validate the diagnostic algorithms; the result showed that a sensitivity of 95.8% and a specificity of 100.0% which indicated can significantly differentiate PCa and BPH groups. In addition, we further verify the validity of the diagnosis algorithm based on PCA-LDA diagnosis algorithm by using receiver operating characteristic (ROC) curves. The results of experiment study suggest that SERS combined with PCA-LDA algorithms has great potential for clinical screening of benign prostate hyperplasia and prostate cancer.

Label-free Surface-Enhanced Raman Spectroscopy for Diagnosis and Analysis of Serum Samples with Different Types Lung Cancer.

Label-free and stable serum analysis based on Ag-NPs/PSi surface-enhanced Raman scattering for noninvasive lung cancer detection

Label-free diagnosis of lung cancer with tissue-slice surface-enhanced Raman spectroscopy and statistical analysis

Label-free surface-enhanced Raman spectroscopy of serum based on multivariate statistical analysis for the diagnosis and staging of lung adenocarcinoma

Label-free surface-enhanced Raman spectroscopy analysis method for liquid biopsy and its application in serum-based lung cancer diagnosis and classification

Application of surface-enhanced Raman spectroscopy to human serum for diagnosing liver cancer

Large Laser Spot-Swift Mapping Surface-Enhanced Raman Scattering on Ag Nanoparticle Substrates for Liquid Analysis in Serum-Based Cancer Diagnosis

Application of Surface-Enhanced Raman Spectroscopy in the Screening of Pulmonary Adenocarcinoma Nodules

Surface-enhanced Raman Scattering Spectroscopy for Potential Noninvasive Nasopharyngeal Cancer Detection

New method of lung cancer detection by saliva test using surface-enhanced Raman spectroscopy.

Detecting Esophageal Cancer Using Surface-Enhanced Raman Spectroscopy (SERS) of Serum Coupled with Hierarchical Cluster Analysis and Principal Component Analysis

Label-free Serum Ribonucleic Acid Analysis for Colorectal Cancer Detection by Surface-Enhanced Raman Spectroscopy and Multivariate Analysis

Ag–Au Nanorods for the Diagnosis of Cervical Cancer by Label-Free Serum Surface-Enhanced Raman Scattering

Rapid and precise detection of cancers via label-free SERS and deep learning

Diagnostic Potential for Gold Nanoparticle Based Surface-Enhanced Raman Spectroscopy to Provide Colorectal Cancer Screening Using Blood Serum Sample

Interpretable Machine Learning-Aided Optical Deciphering of Serum Exosomes for Early Detection, Staging, and Subtyping of Lung Cancer

Label-free detection of serum proteins using surface-enhanced Raman spectroscopy for colorectal cancer screening

Selective Surface Enhanced Raman Scattering for Quantitative Detection of Lung Cancer Biomarkers in Superparticle@MOF Structure

Nasopharyngeal Cancer Detection Based on Blood Plasma Surface-Enhanced Raman Spectroscopy and Multivariate Analysis.

Label-free detection of prostate cancer and benign prostatic hyperplasia based on SERS spectroscopy of Plasma